ITOS(Delisted)
iTeos Therapeutics (ITOS) Stock Statistics, Valuation & Financial Metrics
Total Valuation
iTeos Therapeutics market cap is -- and enterprise value is --.
Share Statistics
iTeos Therapeutics has 44.21M shares outstanding, with a free float of 42.71M.
Valuation Ratios
iTeos Therapeutics's PE ratio is --, PB ratio is --, and PS ratio is --, showing whether the stock looks expensive or cheap.
Solvency
iTeos Therapeutics debt-to-equity ratio is -- and debt-to-assets ratio is 0.21.
Liquidity
iTeos Therapeutics's current ratio is 7.53, quick ratio is 7.53, and cash ratio is --, showing its short-term liquidity position.
Return on Capital
iTeos Therapeutics's ROE is --, ROA is --, and ROIC is --, showing its return on capital profile.
Profitability
iTeos Therapeutics gross margin is --, operating margin is --, and net margin is --.
Operating Efficiency
iTeos Therapeutics's asset turnover is --, inventory turnover is --, and receivables turnover is --, indicating its operating efficiency.
Income Statement
iTeos Therapeutics's revenue is --, gross profit is --, net income is --, and EBITDA is --.
Balance Sheet
iTeos Therapeutics's total debt is --, net debt is --, total equity is --, and cash is --.
Cash Flow Statement
iTeos Therapeutics's operating cash flow is -108.06M, free cash flow is -108.69M, and CapEx is -630.00K.
Dividends & Yields
iTeos Therapeutics dividend yield is --, with a payout ratio of -- and dividend per share of --.
Analyst Rating
iTeos Therapeutics's latest analyst rating is Unrate, with an analyst target price of --.
Company Info
A clinical-stage biopharmaceutical company that developing immuno-oncology therapeutics for cancer
Per Share Metrics
iTeos Therapeutics's EPS is --, book value per share is --, and free cash flow per share is --.
